Fertile ground for education on fertility preservation

Abstract

Many treatments in pediatrics beyond chemotherapy and radiotherapy delivered to oncology patients affect future fertility. Steroids, psychiatric medications, antiepileptic drugs, thyroid medications, novel biologic agents, and illicit drugs can affect fertility in the short- and long-term. In addition, many drugs used in oncology, such as cyclophosphamide, are deployed now in other subspecialties. Some disorders also have intrinsic risks of infertility. In this volume of The Journal, Vakeesan et al report the results of a pilot needs assessment exploring knowledge and practice regarding fertility preservation among non-oncology pediatric subspecialists. Although the investigators explored only a small sample of physicians from a single institution, the results were clear. Despite some recognition by providers that patients are at risk for future sterility, fertility preservation is rarely considered or used among patients with non-oncologic diagnoses when conditions place them at risk either from treatment or the underlying diagnosis. Further attention to understanding future risks of infertility in pediatric patients and increasing fertility preservation are warranted. Article page 253 ▶ Fertility Preservation in Pediatric Subspecialties: A Pilot Needs Assessment Beyond OncologyThe Journal of PediatricsVol. 194PreviewPhysicians from 6 non-oncology pediatric subspecialties were surveyed about fertility preservation (FP) to assess education/service needs. Almost all (96%; 25 of 26) reported having patients at risk of infertility; however, only 58% (15 of 26) had discussed FP with patients' families. Most subspecialists (92%; 23 of 25) would like access to an FP program. Our data support exploring the expansion of FP programs beyond oncology. Full-Text PDF